LL37 (Mens cathelicidine)

154947-66-7

Ropocamptide

C06904-5mg

Anti-infection

Microbiology

CCC (C) C (NC (=O) C (CCCCN) NC (=O) C (CCC (O) =O) NC (=O) C (CCCCN) NC (=O) C (CO) NC (=O) C (CCCCN) NC (=O) C (CCCNC (N) =N) NC (=O) C (CC1=CC=CC=C1) NC (=O) C (CC2=CC=CC=C2) NC (=O) C (CC (O) =O) NC (=O) CNC (=O) C (CC (C) C) NNC (CC (C) C) C=O) C (=O) NCC (=O) NC (CCCCN) C (=O) NC (CCC (O) =O) C (=O) NC (CC3=CC=CC=C3) C (=O) NC (CCCCN) C (=O) NC (CCCNC (N) =N) C (=O) C (=O) C (NNC (C (C) C) C (=O) NC (CCC (N) =O) C (=O) NC (CCCNC (N) =N) C (=O) NC (C (C) CC) C (=O) NC (CCCCN) C (=O) NC (CC (O) =O) C (=O) NC (CC4=CC=CC=C4) C (=O) NC (CC (C) C) C (=O) NC (CCCNC (N) =N) C (=O) NC (CC (N) =O) C (=O) NC (CC (C) C) C (=O) NC (C (C) C) C (=O) N5CCCC5C (=O) NC (CCCNC (N) =N) C (=O) NC (C (C) O) C (=O) NC (CCC (O) =O) C (=O) C (=O) C (CO) NO) C (C) CC

C205H340N60O53

LL37 (Human cathelicidin, Ropocamptide) is a cathelicidin-related antimicrobial peptide with potent chemotactic and immunomodulatory properties.

3 years -20°C powder